Translational Research in Biomaterials (TRB)
Translational Research in Biomaterials (TRB) is an NIH-awarded T32 training grant. The mission of this program is to train young scientists and engineers in the “translation” of their research ideas from the laboratory to the clinic. Innovative translational research is a national priority for the NIH and a central element of BU’s strategic focus on interdisciplinary science. Our program addresses the need for rigorous predoctoral training in biomaterials, translational research, and innovation, and positions TRB fellows to tackle fundamental challenges facing future discovery.
The capstone of the TRB program is the educational curriculum that includes biomaterials courses, a clinical trials course, an entrepreneurial/business course, as well as medical grand rounds and surgery theater for exposure to patient care. Students are exposed to research challenges outside of their specialty and develop interpersonal skills for cross-disciplinary communication. These skills are essential in future careers as graduates join teams that combine diverse backgrounds to meet a common goal or objective in research, development, commercialization, regulatory activities, or public policy.
Training young scientists and engineers in biomaterials and tissue-engineering will facilitate the implementation of biomaterials-based technologies in the clinic. If you are interested in this training program, please contact TRB director, Professor Mark Grinstaff (firstname.lastname@example.org).
TRB is committed to providing a welcoming and accommodating environment for all students. We strongly encourage interested minority, disabled, or economically disadvantaged students to apply.